Francomano Robert 4
4 · STEMLINE THERAPEUTICS INC · Filed Mar 13, 2020
Insider Transaction Report
Form 4
Francomano Robert
Chief Commercial Officer
Transactions
- Sale
Common Stock
2020-03-09$5.00/sh−1,266$6,330→ 197,930 total
Footnotes (3)
- [F1]In connection with the vesting of 3,253 shares on March 8, 2020 a total of 1,266 shares were sold by the Company on March 9, 2020 in order to satisfy the reporting person's tax withholding obligations. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F2]Reflects the weighted average sale price. The range of prices for the shares sold on March 9, 2020 was $5.00 to $5.02. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The reporting person had no discretion with respect to such sale, which was conducted automatically in accordance with the issuer's corporate policies.
- [F3]Of the shares listed, 146,303 shares are restricted stock.